Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria

Annals of Tropical Medicine and Parasitology

Volumn 92, Issue 1, 1998, Pages 31-36

  Karbwang, J ^a   Na Bangchang, K ^a   Thanavibul, A ^a   Molunto, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; DIHYDROARTEMISININ; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIMALARIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; HUMAN; MALARIA FALCIPARUM; MALE; METABOLITE; ORAL DRUG ADMINISTRATION; RELAPSE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE, MULTIPLE; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; SESQUITERPENES;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031973066     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989860148     Document Type: Article

References (10)

1. CHINA CO-OPERATIVE RESEARCH GROUP ON QINGHAOSU and ITS DERIVATIVES AS ANTIMALARIALS (1982). Clinical studies on the treatment of malaria with qinghaosu and its derivatives. Journal of Traditional Chinese Medicine, 2, 17-24.
2. BUNNAG, D., VIRAVAN, C., LOOAREESUWAN, S., KARBWANG, J. & HARINASUTA, T. (1991). Clinical trial of artemether on multidrug resistant falciparum malaria in Thailand: a preliminary report. Southeast Asian Journal of Tropical Medicine and Public Health, 22, 380-385.
3. BUNNAG, D., KARBWANG, J. & HARINASUTA, T. (1992). Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health, 23, 762-767.
4. GIBALDI, M. (1991). Biopharmaceutics and Clinical Pharmacokinetics, 4th Edn. Philadelphia: Lea & Febiger.
5. HELSBY, N. A., WARD, S. A., EDWARDS, G., HOWELLS, R. E. & BRECKENRIDGE, A. M. (1990). The pharmacokineties and activation of proguanil in man: consequences of variability in drug metabolism. British Journal of Clinical Pharmacology, 30, 593-598.
6. KARBWANG, J., NA-BANGCHANG, K., THANAVIBUL, A., BUNNAG, D., CHONGSUPPHAJAISIDDHI, T. & HARINASUTA, T. (1992). Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet, ii, 1245-1248.
7. KARBWANG, J., NA-BANGCHANG, K., MOLUNTO, P., BANMAIRUROI, V. & CONGPUONG, K. (1997). Determination of artemether and its major metabolite, dihydroartemisinin in plasma using high performance liquid chromatography with electrochemical detection. Journal of Chromatography, B, 690, 259-265.
8. LEE, I. S. & HUFFORD, C. D. (1990). Metabolism of antimalarial sesquiterpene lactones. Pharmacology and Therapeutics, 48, 345-355.
9. MYINT, P. T. & SHWE, T. (1987). A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 559-561.
10. MYINT, P. T., SHWE, T. & LIN, S. (1989). Clinical study of the treatment of cerebral malaria with artemether (qinghaosu derivative). Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 72.